References
- Ansari HR, Gajendra PS, Raghava GP (2010). Identification of conformational B-cell epitopes in an antigen from its primary sequence. Immunol Res, 6, 6. https://doi.org/10.1186/1745-7580-6-6
- Bonilla FA, Oettgen HC (2010). Adaptive immunity. J Allergy Clin Immunol, 125, 33-40. https://doi.org/10.1016/j.jaci.2009.09.017
- Boyer CM, Pusztai L, Wiener JR, et al. (1999). Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbb-2 (her-2/neu) gene product p185. Int J Cancer, 82, 525-31. https://doi.org/10.1002/(SICI)1097-0215(19990812)82:4<525::AID-IJC10>3.0.CO;2-J
- Bradford JR, Westhead DR (2005). Improved prediction of protein-protein binding sites using a support vector machines approach. Bioinform, 21, 1487-94. https://doi.org/10.1093/bioinformatics/bti242
- Calabrich A, Fernandes GS, Katz A (2008). Trastuzumab: mechanisms of resistance and therapeutic opportunities. Oncol (Williston Park), 22, 1250-8.
- Chen P, Rayner S, Hu KH (2011). Advances of Bioinformatics tools applied in virus epitopes prediction. Virologica sinica, 26, 1-7. https://doi.org/10.1007/s12250-011-3159-4
- Cho HS, Mason K, Ramyar KX, et al. (2003). Structure of the extracellular region of HER2 alone and in complex with the herceptin fab. Nature, 421, 756-60. https://doi.org/10.1038/nature01392
- Dakappagari NK, Lute KD, Rawale S, et al. (2005). Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities. J Biol Chem, 280, 54-63. https://doi.org/10.1074/jbc.M411020200
- Dakappagari NK, Pyles J, Parihar R, et al. (2003). Chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses. J Immunol, 170, 4242-53. https://doi.org/10.4049/jimmunol.170.8.4242
- Dakappagari N, Douglas D, Triozzi P, et al. (2000). Prevention of mammary tumors with a chimeric Her-2 B-cell epitope peptide vaccine. Cancer Res, 60, 3782-9.
- Disis ML, Cheever MA (1997). HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer. Adv Cancer Res, 71, 343-71. https://doi.org/10.1016/S0065-230X(08)60103-7
- Ercolini AM, Machiels JP, Chen YC, et al. (2003). Identification and character-ization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice. J Immunol, 170, 4273-80. https://doi.org/10.4049/jimmunol.170.8.4273
- Fiore PD (1987). ErbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science, 237, 178-82. https://doi.org/10.1126/science.2885917
- Franklin MC, Carey KD, Vajdos FF, et al. (2004). Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell, 5, 317-28. https://doi.org/10.1016/S1535-6108(04)00083-2
- Garrett JT, Kaumaya P, Pei D, et al. (2007). Peptide based B cell epitope vaccines targeting HER-2/Neu. Degree of doctor of philosophy thesis in the graduate school of the Ohio State University.
- Goede A, Jaeger IS, Preissner R (2005). SUPERFICIAL-surface mapping of proteins via structure-based peptide library design. BMC Bioinform, 6, 223. https://doi.org/10.1186/1471-2105-6-223
- Haro I, Gomara MJ (2004). Design of synthetic peptidic constructs for the vaccine development against viral infections. Curr Protein Pept Sci, 5, 425-33. https://doi.org/10.2174/1389203043379314
- Haste Andersen P, Nielsen M, Lund O (2006). Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci, 15, 2558-67. https://doi.org/10.1110/ps.062405906
- Ishida T, Tsujisaki M, Hinoda Y, et al. (1994). Establishment and characterization of mouse-human chimeric MAb to erbB-2 product. Jpn J Cancer Res, 85, 172-8. https://doi.org/10.1111/j.1349-7006.1994.tb02079.x
- Jasinska J, Wagner S, Radauer C, et al. (2003). Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of HER-2/Neu. Int J Cancer, 107, 976-83. https://doi.org/10.1002/ijc.11485
- Jiang L, Zhou JM, Yin Y, et al. (2010). Selection and identification of B-cell epitope on NS1 protein of dengue virus type 2. Virus Res, 150, 49-55. https://doi.org/10.1016/j.virusres.2010.02.012
- Kulkarni-Kale U, Bhosle S, Kolaskar AS (2005). CEP: a conformational epitope prediction server. Nucleic Acids Res, 33, 168-71.
- Larsen JE, Lund O, Nielsen M (2006). Improved method for predicting linear B cell epitopes. Immunol Res, 2, 2. https://doi.org/10.1186/1745-7580-2-2
- Lax I (1988). Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling. Mol Cell Bio, 8, 1831-4.
- Lebreton A, MoreauV, Lapalud P, et al. (2011). Discontinuous epitopes on the C2 domain of coagulation factor VIII mapped by computer-designed synthetic peptides. Brit J Hem, 155, 487-97. https://doi.org/10.1111/j.1365-2141.2011.08878.x
- Manzalawy Y, Dobbs D, Honavar V (2008b). Predicting flexible length linear B-cell epitopes. 7th international conference on computational systems bioinformatics. CA. 121-31.
- Manzalawy Y, Dobbs D, Honavar V (2008a). Predicting linear B-cell epitopes using string kernels. J Mol Rec, 21, 243-55. https://doi.org/10.1002/jmr.893
- Michalsky E, Goede A, Preissner R (2003). Loops In Proteins (LIP)-a comprehensive loop database for homology modelling. Protein Eng, 16, 979-85. https://doi.org/10.1093/protein/gzg119
- Mittelman A, Lucchese A, Sinha A, Kanduc D (2002). Monoclonal and polyclonal humoral immune response to EC HER-2/Neu peptides with low similarity to the host,s proteome. Int J Cancer, 98, 741-7. https://doi.org/10.1002/ijc.10259
- Miyako H, Kametani Y, Katano I, et al. (2011). Antitumor Effect of New HER2 peptide vaccination based on B cell epitope. Anticancer Res, 31, 3361-8.
- Montgomery R, Makary E, Schiffman K, et al. (2005). Endogenous anti-HER2 antibodies block HER2 phosphorylation and signaling through extracellular signal regulated kinase. Cancer Res, 65, 650-6.
- Moreau V, Fleury C, Piquer D, et al. (2008). PEPOP: computational design of immunogenic peptides. BMC Bioinform, 9, 71. https://doi.org/10.1186/1471-2105-9-71
- Park JW (2008). Unraveling the biologic and clinical complexities of HER2. Clin Breast Cancer, 8, 392-401. https://doi.org/10.3816/CBC.2008.n.047
- Pietras RJ (1995). HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene, 10, 2435-46.
- Ponomarenko J, Bui HH, Li W, et al. (2008). ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform, 9, 514. https://doi.org/10.1186/1471-2105-9-514
- Richard A, Goldsby T, Kindt J, et al. (2000). Kubey Immonology. 5th ed. (W H Freeman and Co (Sd)).
- Rockberg J, Schwenk JM, Uhlen M (2009). Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies. Mol onco, 3, 238-47. https://doi.org/10.1016/j.molonc.2009.01.003
- Saha S, Raghava GP (2004) BcePred:Prediction of continuous B-cell epitopes in antigenic sequences using physicochemical properties. In: Nicosia G, Cutello V, Bentley PJ, Timis J, eds. ICARIS, Springer. Heidelberg. pp 197-204.
- Saha S, Raghava GP (2006). Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins, 65, 40-8. https://doi.org/10.1002/prot.21078
- Sakaguchi S (2000). Regulatory T cells: key controllers of immunologic selftolerance. Cell, 101, 455. https://doi.org/10.1016/S0092-8674(00)80856-9
- Siyi H, Zhiqiang Z, Liangwei L, et al. (2008). Epitope mapping and structural analyses of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism. Proteins, 70, 938-49.
- Tai W, Mahato R, Cheng K (2010). The role of HER2 in cancer therapy and targeted drug delivery-Review. J Control Rel, 146, 264-75. https://doi.org/10.1016/j.jconrel.2010.04.009
- Veje Axelsena T, Holma A, Christiansena G, et al. (2011). Identification of the shortest AB-peptide generating highly specific antibodies against the C-terminal end of amyloid-B42. Vaccine, 29, 3260-9. https://doi.org/10.1016/j.vaccine.2011.02.026
- Vita R, Zarebski L, Greenbaum JA, et al. (2010). The immune epitope database 2.0. Nucleic Acids Res, 38, 854-62. https://doi.org/10.1093/nar/gkp1004
- Wang C, Li Y, Li P (2000). Generation and Characterization of monoclonal antibodies specific for the oncogene product P185 neu/c-erbB-2 by surface epitope masking (SEM). J Chin Immunol, 16, 539-41.
- Wang JN, Feng JN, Yua M, et al. (2004). Structural analyses of the epitopes on erbB2 interacted with inhibitory or non-inhibitor monoclonal antibodies. Mol Immunol, 40, 963-9. https://doi.org/10.1016/j.molimm.2003.09.012
- Wiwanitkit V (2007). Predicted B-cell epitopes of HER-2 oncoprotein by a bioinformatics method: a clue for breast cancer vaccine development. Asian Pac J Cancer Prev, 8, 137-8.
- Yum LY, Robyn LW (2002). Anti-ErbB2 monoclonal antibodies and ErbB2-directed vaccines. Cancer Immunol Immunother, 50, 569-87. https://doi.org/10.1007/s002620100226
- Zhang W, Xiong Y, Zhao M, et al. (2011). Prediction of conformational B-cell epitopes from 3D structures by random forests with a distance-based feature. BMC Bioinform, 12, 341. https://doi.org/10.1186/1471-2105-12-341
Cited by
- In silico Design of Discontinuous Peptides Representative of B and T-cell Epitopes from HER2-ECD as Potential Novel Cancer Peptide Vaccines vol.14, pp.10, 2013, https://doi.org/10.7314/APJCP.2013.14.10.5973
- Bioinformatic prediction of epitopes in the Emy162 antigen of Echinococcus multilocularis vol.6, pp.2, 2013, https://doi.org/10.3892/etm.2013.1142
- Immunization with a novel chimeric peptide representing B and T cell epitopes from HER2 extracellular domain (HER2 ECD) for breast cancer vol.35, pp.12, 2014, https://doi.org/10.1007/s13277-014-2503-y
- analysis vol.36, pp.7, 2014, https://doi.org/10.1111/pim.12111
- In silico docking of methyl isocyanate (MIC) and its hydrolytic product (1, 3-dimethylurea) shows significant interaction with DNA Methyltransferase 1 suggests cancer risk in Bhopal-Gas-Tragedy survivors vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7663
- Production and Characterization of New Anti-HER2 Monoclonal Antibodies vol.34, pp.3, 2015, https://doi.org/10.1089/mab.2014.0092
- In silico vaccine design against type 1 diabetes based on molecular modeling of coxsackievirus B4 epitopes vol.5, pp.1, 2016, https://doi.org/10.1007/s13721-016-0112-y
- Synthetic Peptides are Better Than Native Antigens for Development of ELISA Assay for Diagnosis of Tuberculosis vol.23, pp.2, 2017, https://doi.org/10.1007/s10989-016-9556-2
- In Silico Analysis of Synaptonemal Complex Protein 1 (SYCP1) and Acrosin Binding Protein (ACRBP) Antigens to Design Novel Multiepitope Peptide Cancer Vaccine Against Breast Cancer pp.1573-3904, 2018, https://doi.org/10.1007/s10989-018-9780-z